[Hyperpigmentation].
Hyperpigmentations.
Adrenal Cortical Tropic Hormone
Chloasma
Couleur de la peau
Haemochromatosis
Hormone adrénocorticotropique
Hypermelanosis
Hypermélanose
Hyperpigmentation
Hémochromatose
Skin
Journal
Annales de dermatologie et de venereologie
ISSN: 0151-9638
Titre abrégé: Ann Dermatol Venereol
Pays: France
ID NLM: 7702013
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
pubmed:
21
9
2019
medline:
18
3
2020
entrez:
21
9
2019
Statut:
ppublish
Résumé
The key diagnostic tool for hyperpigmentation is histopathology, which may be accompanied by certain laboratory tests. Hyperpigmentation may result from excess melanin (hypermelanosis), cutaneous iron deposits (hemosiderosis), cutaneous carotene deposits (carotenoderma), or cutaneous deposits of a substance not normally found in the skin (dyschromia). The different types of hypermelanosis may be classified as either localised or generalised. The former generally correspond to skin tumours and may form a cutaneous expression of complex syndromes, which most notably include cardiac abnormalities, or to pigmented forms of inflammatory and/or infectious dermatoses. Diffuse hypermelanosis is frequently a sign of systemic disease, generally metabolic or endocrine disease, or else it may result from pharmaceutical therapy. Herein we review the various causes of hyperpigmentation and the corresponding therapy.
Identifiants
pubmed: 31537319
pii: S0151-9638(19)30214-5
doi: 10.1016/j.annder.2019.05.005
pii:
doi:
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
666-682Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.